Collaborating with Other Care Providers to Optimize Outcomes for Patients Receiving Bispecifics
May 16th 2024The expert panel explores the importance of communication and collaboration among care providers when patients with multiple myeloma who are receiving treatment with bispecific antibodies navigate transitions of care to and from various healthcare settings.
Read More